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More than 40 percent of newly discovered drugs have little or  no water solubility thus the present research 
aimed at the study of improvement of solublisation on dissolution by addition of different solublising agents 
and modification of methods. Irbesartan is the drug of choice. Effect of Solubility on dissolution was studied 
with some solubilizing agents like β-Cyclodextrins, PEG-6000, Polysorbate-80, Cremophore and Resins 
(Doshion). It was seen that Irbesartan give 90 percent release in 1hr with polysorbate-80 where cremophore 
containing tablets showed 97 % release in 1 hr in case of solid dispersion technique and in case of 
complexation technique respectively. Thus the present study concluded that, dissolution rate of poorly 
soluble drug can be increases by using solubilizing agent as well as using different techniques.   
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INTRODUCTION 
Irbesartan is used as angiotensin II receptor antagonists1 
having the chemical formula 2-butyl-3-[{2'- (1H- 
tetrazol-5-yl) {1, 1’- biphenyl}-4-yl} methyl} -1, 3-
diaza- spiro (4, 4) non-1-en-4-one2. The reason behind 
this study is more than 40% of newly discovered drugs 
have little or no water solubility; presently it is a serious 
challenge to the successful development and 
commercialization of new drugs in the pharmaceutical 
industry. More than 90% of drugs approved since 1995 
have poor aqueous solubility, poor membrane 
permeability or both5. Approximately 16% has less than 
optimal performance specifically because of poor 
solubility and low bioavailability. A marketed drug with 
poor water solubility can still show performance 
limitations such as incomplete or erratic absorption6, 
poor bioavailability, and slow onset of action. 
Effectiveness can vary from patient to patient, and there 
can be a strong effect of food on drug absorption. 
Finally, it may be necessary to increase the dose of a 
poorly soluble drug to obtain the efficacy required. 
Although pharmaceutical companies have been able to 
overcome difficulties with very slightly soluble drugs, 
those have aqueous solubility of less than 0.1 mg/ml6. 
Irbesartan is the drug having less water solubility and 
solubility of this drug can be improve by addition of 
solubilizing agents7 as well as using various 
solubilization techniques like Solid dispersion8-10, 
Complexation11-12, Self Microemulsifying13 and 
cosolvency14. 
 
MATERIAL AND METHODS 
Irbesartan was gift sample of Matrix Labs, β-
Cyclodextrins was supplied by Biocon Ltd, PEG-6000 
Visas chemicals limited, Polysorbate-80 from loba 
chem, Cremophore from ISP surfactant and 
Resins(doshion) from Doshi Ion exchange and 
chemical, microcrystalline cellulose from FMC 
Biopolymer, crospovidone from ISP technologies.  
 
Preparation of granules 
Measured amount of Irbesertan are mixed with the 
diluents mentioned in table I for preparation of tablet 
with wet granulation technique taking pregelatinised 
starch as a binder. Solid mass was passing through 22 
mesh size and dried under hot air oven for preparation 
of granules. After preparation of granules, 
preformulation study was carried out. Data are shown in 
table II. 
 
Bulk Density: 
First, 10 g of API (active pharmaceutical ingredient) 
was weighed accurately and kept in a cleaned dried   
graduated measuring cylinder. Then after pouring the 
granules into the measuring cylinder granule bed made 
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uniform without disturbing much. Then the volume was 
measured directly from the graduation marks as ml or 
cc. The volume measure is called is the bulk volume 
and the bulk density is calculated by the following 
formula-  
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =  
𝑤𝑒𝑖𝑔𝑕𝑡 𝑜𝑓 𝑔𝑟𝑎𝑛𝑢𝑙𝑒𝑠
𝑏𝑢𝑙𝑘 𝑣𝑜𝑙𝑢𝑚𝑒
 
Tapped density: 
After measuring the bulk volume, the same measuring 
cylinder was subjected to 500 & 1250 mechanical taps 
with the help of a mechanical tapping machine (tapped 
density measuring apparatus). After tapping, the volume 
was again measured as ml or cc, which is called as 
tapped volume and the tapped density is calculated by 
the following formula- 
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 =
𝑤𝑒𝑖𝑔𝑕𝑡 𝑜𝑓 𝑔𝑟𝑎𝑛𝑢𝑙𝑒𝑠
𝑡𝑎𝑝𝑝𝑒𝑑 𝑣𝑜𝑙𝑢𝑚𝑒
  
Carr’s Compressibility Index  
It is one of the most important parameter to characterize 
the nature of powders and granules. It can be calculated 
from the following equation 
𝐶𝑜𝑚𝑝𝑟𝑒𝑠𝑠𝑖𝑏𝑖𝑙𝑖𝑡𝑦 𝐼𝑛𝑑𝑒𝑥
=  
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦 − 𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑛𝑠𝑖𝑡𝑦
 
Hausner’s Ratio: Hausner’s ratio is an important 
character to determine the flow property of powders and 
granules. This can be calculated by the following 
formula 
𝐻𝑎𝑢𝑠𝑛𝑒𝑟′𝑠 𝑟𝑎𝑡𝑖𝑜 =
𝑇𝑎𝑝𝑝𝑒𝑑 𝑑𝑒𝑠𝑖𝑡𝑦
𝐵𝑢𝑙𝑘 𝑑𝑒𝑛𝑠𝑡𝑖𝑦
 
Particle size determination (Sieve analysis):  An 
accurately weighed (10 g) quantity of pure drug was 
passed through a series of the sieves i.e.25, 30, 35, 45, 
60, 80, and 100,200 with the help of sieve shaker. Then 
the sieves are removed from the sieve shaker and the 
powder retained in each sieve was collected and 
weighed and percentage of powder retained on each 
sieve was calculated using the initial weight taken.  
Solubility determination in different media:  
A quantitative determination of solubility was done by 
preparing saturated solutions of drug in different 
medium i.e. 0.1 N HCL, water, pH 6.8, 6.5 and 7.5 
Phosphate buffer, pH 4.5 acetate buffer respectively by 
adding excess amount of drug into the media and placed 
in a sonicator for 2 hours. The resultant solution were 
filtered, diluted and checked for absorbance at the 
respective medium blank and comparing the 
absorbance, amount of drug was determined.  
Preparation of tablet 
After preparation of Irbesartan granules are ready for 
preparation for tablet compression. Finally magnesium 
stearate is mixed with irbesertan granules which are 
used as a lubricating agent just prior to tablet punch. 
Tablets were manufactured as per the formula given in 
table I using 8 station tablet compression machine 
(cadmach). 
In process Test 
Compressed tablet may be characterized by a number of 
specifications given in table I such as size, shape, 
thickness, hardness, friability, weight, and disintegration 
time. 
Weight variation 
After the tablet machine is in operation, the weights of 
tablets are checked routinely to ensure the proper 
weights of tablet are being made. 20 tablets were taken 
each time and weighed accurately to determine the 
weight variation. 
Hardness 
Hardness determination are made a throughout the 
tablet runs to determine the need for pressure 
adjustment on the tablet compression machine. 5 tablets 
are taken for checking the hardness test. The average 
was calculated after performing the hardness test with 
Dr. Schleiunger. 
Friability 
20 tablets are taken doing the friability using Roche's 
friabilator for 4mins at 25rpm. Friability was calculated 
by using the formula- 
% 𝐹𝑟𝑖𝑎𝑏𝑖𝑙𝑖𝑡𝑦 =  
𝑊0 −𝑊
𝑊0
 × 100 
Where, W0 = Weight of tablets before rotation 
W= Weight of tablets after rotation 
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Table I: Composition of different tablet containing irbesartan, valsartan and telmisartan 
Ingredients FT F1 F2 F3 F4 F5 F6 
Irbesartan 300 300 300 300 300 300 300 
LM 120 268 258  258 258 258 
MCC 85.5       
PgS 60       
Aerosil 200 6       
CCS 24 28 28 12 28 28 28 
MgS 4.5 4 4 4 4 4 4 
PEG-6000   10     
βCD    254    
Polysorbate 80     10   
Cremophore      10  
Resins (Doshion)       10 
LM- Lactose Monohydrate, MCC- Microcrystalinecellulose, PgS- Pregelatinized starch,  
CCS- Crosscarmilose sodium, MgS- Magnesium stearate, PEG- Polyethylene glycol,  
CD- Cyclodextrine, DCP- Dibasic calcium phosphate 
 
Disintegration time 
Uncoated tablets should be disintegrating within Indian 
Pharmacopoeia limit in water at 37 °C using I.P. 
disintegration test apparatus. 
 
Thickness 
Thickness of the tablet is controlled during production 
and it was determined by vernier caliper in mm. 
 
Dissolution Studies 
 The dissolution was assessed using standard USP 
Apparatus II in 900ml of 0.1 N HCl. The stirring speed 
was 100 rpm. Total 3 tablets of each formulation were 
taken for release study. Temperature was maintained at 
37  0.5º C throughout the experiment. Dissolution 
study was carried out for 60 min with sampling intervals 
of 5, 10, 15, 30, 45 and 60 mins. After collection of 
sample in each interval, dissolution medium was 
replenished with the same volume of media. In each 
sampling time 10ml was pipette out and filtered through 
0.45+ 0.1 mm diameter filter paper and analyzed for the 
% drug release in U.V. spectrophotometer at 259 mm.15  
 
RESULTS AND DISCUSSION 
The present research aimed at the study of improvement 
of solublisation on dissolution by addition of different 
solublising agents and modification of methods. Effect 
of Solubility on dissolution was studied with some 
solubilizing agents like β-Cyclodextrins, PEG-6000, 
Polysorbate-80, Cremophore and Resins (Doshion). 
Tablets are prepared as per formula mentioned in table 
I. Before tablet compression, a preformulation study 
was carried out. It was seen that, all the parameter like 
bulk density, Tapped density, Compressibility index and 
Hausner’s ratio are in their concentration range as per 
standard reference books and journals. The outcomes 
were as per expectation and results were satisfactory 
shown in table II.  After comparing physical parameter 
of all tablets, it was seen that F1, F2 and F6 have low 
hardness, friability and thickness as compare to others 
except disintegration time shown in table II.  
The processes such as micronisation, jet milling, spray 
drying and freeze drying are not applied due to fineness 
nature of all API. Solid dispersion, complexation are 
most common method for solubility enhancement. With 
surfactants such as polysorbate-80, cremophore has also 
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great effect on dissolution. Solid dispersion with PEG-
6000 is a critical process for solubility. In case of F3, F4 
and F5 showed the better dissolution results observed in 
case of adding polysorbate-80 upto 90% in 1hr. shown 
in Figure I. Other processes are not so acceptable due to 
its poor release rate.  
To analyze the in vitro release data various kinetic 
models were used to describe the release kinetics. The 
zero order rate Eq. (1) describes the systems where the 
drug release rate is independent of its concentration, (2) 
Higuchi (1963) described the release of drugs from 
insoluble matrix as a square root of time dependent 
process based on Fickian diffusion. From the release 
kinetics it was seen that the r2 (table II) value of zero 
order kinetics is not linear when compare with 
Higuchi’s plot. The r2 value was between the ranges 
0.743 to 0.955 which much linear with regression 
coefficient that means the release of drug from the 
formulation was diffusion controlled.16 
 
Table II: Parameter of drugs and in process quality control test of tablets 
Parameters Specification Irbesartan 
Appearance Crystalline Crystalline 
Melting Point (ºC) 100-300 428-429.5 
Solubility mg/ml 
0.1N HCl 
Water 
pH 4.6 acetate buffer 
pH 6.5 phosphate buffer 
pH 6.8 phosphate buffer 
pH 7.5 phosphate buffer 
0.5 
0.5 
0.5 
0.5 
0.5 
0.5 
0.354 
0.579 
0.798 
0.721 
------ 
------ 
Bulk density (gm/ml) 0.3 0.2 
Tapped density (gm/ml) 0.3 0.28 
Compressibility index 30 28.5 
Hausner’s ratio 2 1.4 
Weight (mg) 600 600 
Hardness (kg/cm2) 5-15 10.8 
Friability (%) 0.2 0.2 
Thickness (mm) 5.15±0.15 5.15 
Disintegration (min) Within 15min 2.45 
Punch detail (mm) 17.1×9.15 17.1×9.15 
Release kinetics Zero order Higuchi’s plot 
Ft R
2=0.393 R2=0.839 
F1 R
2=0.535 R2=0.921 
F2 R
2=0.468 R2=0.888 
F3 R
2=0.391 R2=0.743 
F4 R
2=0.338 R2=0.565 
F5 R
2=0.322 R2=0.541 
F6 R
2=0.530 R2=0.955 
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CONCLUSION 
The present research aimed at the study of 
improvement of solubility on dissolution by addition of 
different solublising agents and modification of 
methods. Some of the solubilizing agents were showed 
satisfactory result on dissolution. From the present 
study, it can be concluded that solid dispersion and 
complexation method can be used for increasing the 
solubility of poorly soluble drugs with addition of 
solubilizing agents. 
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